DE69417169T2 - Antineoplastische pharmazeutische Zusammensetzung enthaltend ein Fumagillolderivat und einen Platinkomplex - Google Patents

Antineoplastische pharmazeutische Zusammensetzung enthaltend ein Fumagillolderivat und einen Platinkomplex

Info

Publication number
DE69417169T2
DE69417169T2 DE69417169T DE69417169T DE69417169T2 DE 69417169 T2 DE69417169 T2 DE 69417169T2 DE 69417169 T DE69417169 T DE 69417169T DE 69417169 T DE69417169 T DE 69417169T DE 69417169 T2 DE69417169 T2 DE 69417169T2
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
platinum complex
composition containing
fumagillol derivative
antineoplastic pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69417169T
Other languages
English (en)
Other versions
DE69417169D1 (de
Inventor
Shuichi Ikeyama
Toshihiro Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE69417169D1 publication Critical patent/DE69417169D1/de
Application granted granted Critical
Publication of DE69417169T2 publication Critical patent/DE69417169T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69417169T 1993-09-24 1994-09-23 Antineoplastische pharmazeutische Zusammensetzung enthaltend ein Fumagillolderivat und einen Platinkomplex Expired - Fee Related DE69417169T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23834193 1993-09-24

Publications (2)

Publication Number Publication Date
DE69417169D1 DE69417169D1 (de) 1999-04-22
DE69417169T2 true DE69417169T2 (de) 1999-07-22

Family

ID=17028767

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69417169T Expired - Fee Related DE69417169T2 (de) 1993-09-24 1994-09-23 Antineoplastische pharmazeutische Zusammensetzung enthaltend ein Fumagillolderivat und einen Platinkomplex

Country Status (3)

Country Link
EP (1) EP0658342B1 (de)
AT (1) ATE177632T1 (de)
DE (1) DE69417169T2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2210600A1 (en) * 1996-07-17 1998-01-17 Takashi Houkan Inhibitor of tumor metastasis or recurrence
AU3968597A (en) * 1996-08-02 1998-02-25 Children's Medical Center Corporation Method of regulating the female reproductive system through angiogenesis inhibitors
AU2002239479B2 (en) 2000-11-01 2006-11-09 Praecis Pharmaceuticals Incorporated Peptides as Met-AP2 inhibitors
US6919307B2 (en) 2000-11-01 2005-07-19 Praecis Pharmaceuticals, Inc. Therapeutic agents and methods of use thereof for the modulation of angiogenesis
CA2381829A1 (en) * 2001-05-18 2002-11-18 Margaret Ann Smith Dordal A method for tumor treatment with fumagillol derivatives
WO2002094183A2 (en) * 2001-05-18 2002-11-28 Tap Pharmaceutical Products Inc. A method for tumor treatment with fumagillol derivatives
FR2886855B1 (fr) * 2005-06-08 2009-07-17 Agronomique Inst Nat Rech Utilisation de la fumagilline et de ses derives pour augmenter la biodisponibilite des lactones macrocyliques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0415294A3 (en) * 1989-08-31 1991-06-12 Takeda Chemical Industries, Ltd. Cyclohexanol derivatives, production and use thereof
TW282399B (de) * 1990-05-25 1996-08-01 Takeda Pharm Industry Co Ltd
DE69114782T2 (de) * 1990-08-08 1996-04-18 Takeda Chemical Industries Ltd Intravaskulär embolisierendes Mittel mit Gehalt an einem die Angiogenesis hemmenden Stoff.

Also Published As

Publication number Publication date
DE69417169D1 (de) 1999-04-22
ATE177632T1 (de) 1999-04-15
EP0658342A1 (de) 1995-06-21
EP0658342B1 (de) 1999-03-17

Similar Documents

Publication Publication Date Title
DE58901934D1 (de) Verschlussanordnung fuer pharmazeutische flaschen.
FI935073A (fi) Nya tiopyranopyrrolderivat, framstaellning av dem och dessa innehaollande farmaceutiska sammansaettningar
DE68912232D1 (de) Konjugate zytotoxischer Arzneimittel.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
FR2700167B1 (fr) Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant.
DE498268T1 (de) 5-oxo-l-prolinderivate und deren pharmazeutischen herstellungen.
DE69133371D1 (de) Pharmazeutische wirksame Benzochinazolin Verbindungen
EP0620004A4 (de) Medizinische zusammensetzung.
ZA9110018B (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity.
ATE177632T1 (de) Antineoplastische pharmazeutische zusammensetzung enthaltend ein fumagillolderivat und einen platinkomplex
NO892764L (no) Medikamentell administreringsform for droevtyggere.
DE68901859T2 (de) 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung.
DE515995T1 (de) N-(5-thioxo-l-propyl)-l-cystein und derivate, deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
DE69318153D1 (de) Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon
FI895463A0 (fi) Farmaceutiska kompositioner, som innehaoller labdanditerpenoidderivat och pyrimido (6,1-a) isokinolin -4-onderivat, samt anvaendning daerav.
DE68915203T2 (de) Pharmazeutische Mischungen.
FI901199A0 (fi) Nya steroiddioler, dessa innehaollande farmaceutiska foereningar och foerfarande foer framstaellning av dem.
FI915930A (fi) Nya 15-nitro-2b,3b-dihydro- och 15-nitro-2b,3b,6,7-tetrahydrotabersoninderivater, farmaceutiska sammansaettningar innehaollande dem och deras framstaellningsmetod.
DE58905160D1 (de) Pharmazeutische zubereitung.
DE68902056T2 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
FI924281A0 (fi) Tienocyklopentanonoximers etrar, deras framstaellning och farmaceutiska sammansaettningar innehaollande dem.
DE68908838T2 (de) Pharmazeutisch wirksame Dithioketen-Derivaten.
DE69208913D1 (de) 2-Oxindol-1-carboxamidderivat enthaltendes Arzneimittel zur rektalen Verabreichung
FR2685870B1 (fr) Medicament anticancereux.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee